Eisai Launches Latest Book in Comic Book Series:  “Medikidz Explain Playing Sports With Epilepsy”

Living with epilepsy can be challenging, and even scary at times, but it doesn’t have to stop you from pursuing your dreams. With the help…

CURE: NOW ACCEPTING 2017 Seminar Series Applications!

Host a 2017 CURE Seminar At Your Institution CURE is now accepting applications for the 2017 Frontiers in Research Seminar Series! Approximately 10 seminars will be…

CURE Travel Awards

CURE is Proud to Sponsor the Gordon Research Seminar and Gordon Research Conference on Mechanisms of Epilepsy & Neuronal Synchronization GRS August 20-21, 2016 | GRC August 21-26,…

Novartis drug Afinitor® significantly reduces seizures in Phase III study of patients with tuberous sclerosis complex

– Everolimus is the first adjunctive therapy shown in a prospective randomized Phase III study to achieve clinically significant seizure control in TSC patients(1) –…

Start typing and press Enter to search

Shopping Cart